Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Relation of beta-blocker use with frequency of hospitalization for heart failure in patients with left ventricular diastolic dysfunction (from the Heart and Soul Study).

Smith DT, Farzaneh-Far R, Ali S, Na B, Whooley MA, Schiller NB.

Am J Cardiol. 2010 Jan 15;105(2):223-8. doi: 10.1016/j.amjcard.2009.08.677.

2.

Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul Study.

Welles CC, Ku IA, Kwan DM, Whooley MA, Schiller NB, Turakhia MP.

J Am Coll Cardiol. 2012 Feb 14;59(7):673-80. doi: 10.1016/j.jacc.2011.11.012.

3.

Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.

McCullough PA, Barnard D, Clare R, Ellis SJ, Fleg JL, Fonarow GC, Franklin BA, Kilpatrick RD, Kitzman DW, O'Connor CM, Piña IL, Thadani U, Thohan V, Whellan DJ; HF-ACTION Investigators.

Clin Cardiol. 2013 Oct;36(10):611-20. doi: 10.1002/clc.22181. Epub 2013 Aug 8.

4.

Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.

Badano LP, Albanese MC, De Biaggio P, Rozbowsky P, Miani D, Fresco C, Fioretti PM.

J Am Soc Echocardiogr. 2004 Mar;17(3):253-61.

PMID:
14981424
5.

Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease.

Ren X, Ristow B, Na B, Ali S, Schiller NB, Whooley MA.

Am J Cardiol. 2007 Jun 15;99(12):1643-7. Epub 2007 Apr 27.

6.

Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease.

Chang TI, Yang J, Freeman JV, Hlatky MA, Go AS.

J Card Fail. 2013 Mar;19(3):176-82. doi: 10.1016/j.cardfail.2013.01.006.

7.

Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.

Pascual-Figal DA, Redondo B, Caro C, Manzano S, Garrido IP, Ruipérez JA, Valdés M.

Am J Cardiol. 2008 Dec 15;102(12):1711-7. doi: 10.1016/j.amjcard.2008.07.059. Epub 2008 Sep 20.

PMID:
19064029
8.

Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).

Spies C, Farzaneh-Far R, Na B, Kanaya A, Schiller NB, Whooley MA.

Am J Cardiol. 2009 Oct 1;104(7):883-9. doi: 10.1016/j.amjcard.2009.05.027.

PMID:
19766751
9.

C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study.

Williams ES, Shah SJ, Ali S, Na BY, Schiller NB, Whooley MA.

Eur J Heart Fail. 2008 Jan;10(1):63-9. Epub 2007 Dec 21.

10.

Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.

Fox K, Komajda M, Ford I, Robertson M, Böhm M, Borer JS, Steg PG, Tavazzi L, Tendera M, Ferrari R, Swedberg K.

Eur Heart J. 2013 Aug;34(29):2263-70. doi: 10.1093/eurheartj/eht101. Epub 2013 Mar 26.

11.

First-degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease: data from the Heart and Soul Study.

Crisel RK, Farzaneh-Far R, Na B, Whooley MA.

Eur Heart J. 2011 Aug;32(15):1875-80. doi: 10.1093/eurheartj/ehr139. Epub 2011 May 23.

13.

Progression of left ventricular diastolic dysfunction and risk of heart failure.

Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, Jacobsen SJ, Rodeheffer RJ.

JAMA. 2011 Aug 24;306(8):856-63. doi: 10.1001/jama.2011.1201.

14.
15.

Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.

Bennett KM, Hernandez AF, Chen AY, Mulgund J, Newby LK, Rumsfeld JS, Hochman JS, Hoekstra JW, Ohman EM, Gibler WB, Roe MT, Peterson ED.

Am J Cardiol. 2007 May 15;99(10):1351-6. Epub 2007 Apr 9.

PMID:
17493458
16.

Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.

Verbrugge FH, Duchenne J, Bertrand PB, Dupont M, Tang WH, Mullens W.

Am J Cardiol. 2013 Dec 15;112(12):1913-20. doi: 10.1016/j.amjcard.2013.08.013.

PMID:
24286620
17.

Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.

Linde C, Gold MR, Abraham WT, St John Sutton M, Ghio S, Cerkvenik J, Daubert C; REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction Study Group.

Eur Heart J. 2013 Sep;34(33):2592-9. doi: 10.1093/eurheartj/eht160. Epub 2013 May 2.

18.

Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.

Dhaliwal AS, Bredikis A, Habib G, Carabello BA, Ramasubbu K, Bozkurt B.

Am J Cardiol. 2008 Nov 15;102(10):1356-60. doi: 10.1016/j.amjcard.2008.07.014. Epub 2008 Sep 12.

PMID:
18993155
19.

Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: data from the Heart and Soul Study.

McManus DD, Shah SJ, Fabi MR, Rosen A, Whooley MA, Schiller NB.

J Am Soc Echocardiogr. 2009 Feb;22(2):190-7. doi: 10.1016/j.echo.2008.11.005. Epub 2008 Dec 11.

20.

Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.

Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M; French National College of Cardiologists.

Arch Cardiovasc Dis. 2012 Jun-Jul;105(6-7):355-65. doi: 10.1016/j.acvd.2012.04.003. Epub 2012 Jun 28.

Items per page

Supplemental Content

Write to the Help Desk